IPO

Remus Pharmaceuticals Limited IPO

NSE SME

Listed On: May 29, 2023 at ₹ 1711.25

₹ 122900 /100 Shares

Check Allotment

Remus Pharmaceuticals Limited IPO Details

17 May, 2023

Open Date

19 May, 2023

Close Date

24 May, 2023

Allotment Date

29 May, 2023

Listing Date

Issue Price

₹1150-1229 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

NSE SME

Registrar

Link Intime India Private Ltd

List Price

1711.25

Listing Date

2023-05-29

Market Lot

100 Shares (₹122,900/-)

Lead Manager

Beeline Capital Advisors Pvt Ltd

Issue Size

Fresh Issue : 388,000 shares(aggregating up to ₹47.69 Cr)

Retail Portion

N/A

Subscription

57.21 times

IPO Docs

DRHP RHP

Remus Pharmaceuticals Limited IPO Subscription Details

As onQIB / NIIRetailTotal
Shares Offered / Reserved347,040 / 1,179,2421,944,1183,470,400
Day 1 - 17-05-23 06:00 PM0.00 / 2.85 x2.85 x1.43 x
Day 2 - 18-05-23 06:00 PM1.48 / 12.25 x10.79 x6.36 x
Day 3 - 19-05-23 06:00 PM10.75 / 229.31 x49.81 x57.21 x
Total No. of Applications: 48,370 (Approx)

Remus Pharmaceuticals Limited Valuations

Earnings Per Share (EPS)

₹N/A/-

P/E Ratio

N/A

RoNW

N/A%

Net Asset Value (NAV) - Post Issue

₹N/A/-

Remus Pharmaceuticals Limited Company Financials All values are in ₹ Lakh

30-Dec-2231-Mar-2231-Mar-2131-Mar-20
Assets3,352.961,590.931,104.96530.36
Revenue3,361.202,543.711,922.451,276.89
Profit After Tax643.90338.57102.5881.16

About The Company

Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.

The product offerings of the company can be classified into two major categories:
APIs: Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.

Finished Pharmaceutical Formulations: Finished pharmaceutical formulations are therapeutic drugs available in different dosage forms.

The product portfolio consists of 429 products, as on January 31, 2023. They operate under different brand names across the globe. As on January 31, 2023, the company has 295 products registered in a total of 13 countries. As on January 31, 2023, a total of 134 ;products are under the process of registration in 16 countries.

As on January 31, 2023, Remus Pharmaceuticals had business-to-business supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply.

The company has cultivated strong and dependable customer relationships and its clients are spread in more than 20 countries. These clients range from Generic distributors, regional distributors, and Multinational distributors to Hospitals and Clinics.

Read More

Remus Pharmaceuticals Limited - Promoter(s)

Pre Issue Share Holding: 92.82%

Post Issue Share Holding: %

Company Promoter(s)

  1. Mr. Arpit Deepakkumar Shah
  2. Ms. Roma Vinodbhai Shah
  3. Mr. Swapnil Jatinbhai Shah
  4. Mrs. Anar Swapnil Shah

Remus Pharmaceuticals Limited IPO - Issue Objectives

  1. To Meet Working Capital Requirements
  2. Funding investments for acquisitions and general corporate purposes
  3. To meet Public Issue Expenses

Remus Pharmaceuticals Limited IPO - FAQs

Ans. Remus Pharmaceuticals Limited IPO is a SME IPO. The issue is priced at ₹1150-1229 per equity share. The minimum order quantity is 100 Shares. The IPO opens on May 17, 2023, and closes on May 19, 2023. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Ans. The Remus Pharmaceuticals Limited IPO opens on May 17, 2023 and closes on May 19, 2023.

Ans. The size of Remus Pharmaceuticals Limited IPO is Fresh Issue : 388,000 shares(aggregating up to ₹47.69 Cr).

Ans. The IPO price band is set between ₹1150-1229 per equity share.

Ans. To apply for Remus Pharmaceuticals Limited IPO IPO, follow the steps given below:

  • - Open the IPO Ji App or Website
  • - Find Remus Pharmaceuticals Limited IPO in the List of IPOs
  • - Press "Apply" Button
  • - Select Your Demat Account
  • - Select Your Shares Quantity and Submit
  • - Track Your IPO Status

Ans. The share allotment date of Remus Pharmaceuticals Limited IPO is May 24, 2023.

Ans. The Remus Pharmaceuticals Limited IPO will be listed on May 29, 2023.

Ans. Follow the steps to check the allotment status for Remus Pharmaceuticals Limited IPO here.